Lots of interest in this target for both diagnostic imaging and therapeutic applications.
What is a “Pan-Cancer” Target? Pan is Greek for “all”, meaning a target that works for a range of #cancers. Novel #radiopharmaceutical imaging studies support Fibroblast Activation Protein-α (FAP) as the next promising pan-cancer target. #oncology https://lnkd.in/ePh7Z6Zh
Tumor-seeking radiopharmaceuticals are charting a new course in #oncology, with promise for targeted treatments with fewer side effects. Learn more in this article by Elie Dolgin, originally published in Knowable Magazine: https://lnkd.in/ekmqKM6s.
In the rapidly evolving landscape of oncology, targeted radiopharmaceuticals are making waves as a revolutionary treatment option. But what makes them so promising, and how can the industry navigate the challenges ahead? In this latest pharmaphorum article by Vikram Gosain, learn more about the science behind these therapies, their impact on patient outcomes, and the strategic considerations for stakeholders in this space. Read the article here: https://lnkd.in/eykF6Myx #Oncology #Radiopharmaceuticals #TargetedTherapies #CancerTreatment #PharmaInnovation
I'm very pleased to serve on the Clinical and Regulatory Advisory Board of AffyImmune Therapeutics - Hagop Youssoufian https://lnkd.in/dprenUyF #Cancer #Career #CARTTherapies #LungCancer #OncoDaily #Oncology #ThyroidCancer #Biotechnology
Great news! Our poster, built in conjunction with Otto-von-Guericke University Magdeburg, has been approved for PAGE 2024. Titled “Data-Driven Discovery of Interpretable Feedback Mechanisms in Acute Myeloid Leukemia using DeepPumas,” this poster was developed by Julius Martensen, Niklas Korsbo, Sebastian Sager, and Vijay Ivaturi. See it on display at #PAGE2024, visit booth #16 for additional questions, or learn more about DeepPumas here: https://lnkd.in/gmZtcp4p #AML #Oncology #DrugDevelopment #ClinicalData #SciML #MachineLearning #Biology #Pharmacology
Manta for oncology workflows 🧬 Running oncology workflows can be challenging. Working with tricky sample types and the constant struggle to meet those sky-high DNA/RNA quality standards. But, we’ve built Manta to tackle exactly these. ✅Flexible with sample load: Often oncology labs don’t get a heap of samples together. Manta can run just 1 or up to 32 samples in one go. ✅Enables various oncology applications: including diagnostics, BCR-ABL testing, and liquid biopsy research among others. ✅Optimal results: Manta delivers optimal results every time, no ifs, ands, or buts. If your lab works in the oncology sector and you’re looking to automate extraction workflows, let’s talk more: https://lnkd.in/guJ8VMND #oncology #molecularbiology #cancerdiagnostics #liquodbiopsy
Innovent is presenting clinical data on our first-in-class PD-1/IL-2α-bias bispecific antibody fusion protein (IBI363) at the 2024 ESMO Virtual Plenary, June 13-14. Read below about this antibody's promising safety signals, its broad anti-tumor activity and its applicability across tumor types. #ESMOVirtualPlenary #oncology #InnoventBiologics https://lnkd.in/guaqFQmN
A device to make chemotherapy more effective and less toxic arrives from Massachusetts Institute of Technology (MIT) in Boston (USA). How? By working on the correct dosage of chemotherapy drugs. 🔹 Find out more in the latest IBSA Foundation for scientific research blog article: https://lnkd.in/eT9G_DJ7 #IBSA #CaringInnovation #ScienceBeyondFrontiers #IBSAFoundation #chemotherapy #oncology #scientificresearch
🔥Don't miss this article from ESMO - European Society for Medical Oncology on how oligoprogression in metastatic #NSCLC could be effectively treated with SBRT plus standard-of-care ✅CURB study provides the first randomised evidence of benefit from SBRT in patients with oligoprogressive NSCLC ✅Analysis of #ctDNA from CURB study provides a valuable insight into potential utility of this technology Read here👇 https://ow.ly/4K0550QpunV #MedEd #Oncology
Explore the latest oncology innovations: New analysis of 5,000+ Commercial Opportunity Projects from over 100 leading universities worldwide. Book your 30 min demo here: https://lnkd.in/dii3FECB #cancer #oncology #cancerresearch #drugdiscovery #drugdevelopment #1stoncology #biotech #pharma #immunooncology #clinicaltrials #academic #businessdevelopment #searchandevaluation #commercialopportunities
Our second session of day 2 at the Hail First Therapeutics Summit, titled "Oncology / Hematology Pharmacotherapy Update" starts with the moderator Dr.Yassmen Alsagheh #HTS24
